Loading compare…
11 funds hold both · as on Aug 2026
Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 11 mutual funds hold active equity positions in both Sun Pharmaceutical Industries and Viyash Scientific. The scheme with the highest combined exposure is Kotak Healthcare Fund (Kotak MF), which holds a 13.96% stake in Sun Pharmaceutical Industries and a 2.01% stake in Viyash Scientific, amounting to a combined conviction weight of 15.97%.
When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.
| Fund | Sun wt. | Viyash wt. | Combined |
|---|---|---|---|
| Kotak Healthcare FundKotak MF · Sectoral / Thematic | 13.96% | 2.01% | |
| Motilal Oswal MF · Equity (Diversified) | 12.92% | 0.25% | |
| UTI - Healthcare FundUTI MF · Sectoral / Thematic | 8.25% | 1.54% | |
| Kotak Manufacture In India FundKotak MF · Equity (Diversified) | 4.76% | 1.76% | |
| Kotak MNC FundKotak MF · Sectoral / Thematic | 3.44% | 1.41% | |
| Kotak ELSS Tax Saver FundKotak MF · ELSS (Tax Saver) | 2.49% | 1.45% | |
| Kotak Special Opportunities FundKotak MF · Sectoral / Thematic | 1.63% | 1.96% | |
| Kotak Consumption FundKotak MF · Sectoral / Thematic | 1.15% | 1.52% | |
| Kotak Contra FundKotak MF · Contra | 1.59% | 0.95% | |
| IB18-Groww Nifty Total Market Index FundGroww MF · Index Fund | 1.00% | 0.02% | |
| Kotak Balanced Advantage FundKotak MF · Hybrid | 0.71% | 0.17% |
These funds hold both stocks — see how much their entire portfolios overlap.
Check overlap of top funds →“Holds both” = the fund discloses an equity position in each stock in its latest public monthly portfolio (as on Aug 2026). Weight = the position as a % of that fund's portfolio. ISIN-verified from AMC disclosures. Not investment advice.